UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049209
Receipt No. R000056049
Scientific Title Endoscopic papillary balloon dilation can be safely performed in patients with dual antiplatelet therapy: A pilot study
Date of disclosure of the study information 2022/10/18
Last modified on 2022/10/13 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Endoscopic papillary balloon dilation can be safely performed in patients with dual antiplatelet therapy: A pilot study
Acronym Endoscopic papillary balloon dilation is safe for patients with dual antiplatelet therapy
Scientific Title Endoscopic papillary balloon dilation can be safely performed in patients with dual antiplatelet therapy: A pilot study
Scientific Title:Acronym Endoscopic papillary balloon dilation is safe for patients with dual antiplatelet therapy
Region
Japan

Condition
Condition common bile duct stone
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 investigation for safe
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes bleeding
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria with antiplatelet thrapy
Key exclusion criteria without antiplatelet thrapy
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Sakue
Middle name
Last name Masuda
Organization Shonan Kamakura General Hospital
Division name Gastrointestinal Medicine Center
Zip code 247-8533
Address 1370-1 Okamoto, Kamakura, Kanagawa
TEL 0467-46-1717
Email sakue3939@yahoo.co.jp

Public contact
Name of contact person
1st name Sakue
Middle name
Last name Masuda
Organization Shonan Kamakura General Hospital
Division name Gastrointestinal Medicine Center
Zip code 247-8533
Address 1370-1 Okamoto, Kamakura, Kanagawa
TEL 0467-46-1717
Homepage URL
Email sakue3939@yahoo.co.jp

Sponsor
Institute Shonan Kamakura General Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization mirai-iryo
Address 1-7-8 Kojimachi, Chiyoda, Tokyo
Tel 03-3263-4801
Email tajima@mirai-iryo.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 31
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 04 Month 01 Day
Date of IRB
2022 Year 10 Month 18 Day
Anticipated trial start date
2014 Year 04 Month 01 Day
Last follow-up date
2022 Year 08 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information EPBD for DAPT or SAPT groups.

Management information
Registered date
2022 Year 10 Month 13 Day
Last modified on
2022 Year 10 Month 13 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056049